Rheumatoid arthritis
Not yet recruitingA study to compare two different dosing methods of tocilizumab in patients with rheumatoid arthritis who have low disease activity or are in clinical remission
A study to compare two different dosing methods of tocilizumab in patients with rheumatoid arthritis who have low disease activity or are in clinical remission
- Disease:Rheumatoid arthritis
- Substances:Tocilizumab
France- Participants:18–64 years · 65+ years
- Substances:Tocilizumab
- Sponsor:Centre Hospitalier Universitaire De Nice







